1921
Volume 93, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Ebola virus disease (EVD) is a life-threatening zoonosis caused by infection with the Ebola virus. Since the first reported EVD outbreak in the Democratic Republic of the Congo, several small outbreaks have been reported in central Africa with about 2,400 cases occurring between 1976 and 2013. The 2013–2015 EVD outbreak in west Africa is the first documented outbreak in this region and the largest ever with over 27,000 cases and more than 11,000 deaths. Although EVD transmission rates have recently decreased in west Africa, this crisis continues to threaten global health and security, particularly since infected travelers could spread EVD to other resource-limited areas of the world. Because vaccines and drugs are not yet licensed for EVD, outbreak control is dependent on the use of non-pharmaceutical interventions (e.g., infection control practices, isolation of EVD cases, contact tracing with follow-up and quarantine, sanitary burial, health education). However, delays in diagnosing and reporting EVD cases in less accessible rural areas continue to hamper control efforts. New advances in rapid diagnostics for identifying presumptive EVD cases and in mobile-based technologies for communicating critical health-related information should facilitate deployment of an early response to prevent the amplification of sporadic EVD cases into large-scale outbreaks.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0229
2015-09-02
2017-09-26
Loading full text...

Full text loading...

/deliver/fulltext/14761645/93/3/438.html?itemId=/content/journals/10.4269/ajtmh.15-0229&mimeType=html&fmt=ahah

References

  1. Marston HD, Folkers GK, Morens DM, Fauci AS, , 2014. Emerging viral diseases: confronting threats with new technologies. Sci Transl Med 6: 253ps10.[Crossref]
  2. World Health Organization, 2015. Ebola Situation Reports. Available at: http://apps.who.int/ebola/en/current-situation/ebola-situation-report. Accessed June 29, 2015.
  3. Burd EM, , 2015. Ebola virus: a clear and present danger. J Clin Microbiol 53: 48.[Crossref]
  4. Pattyn S, van der Groen G, Jacob W, Piot P, Courteille G, , 1977. Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire. Lancet 309: 573574.[Crossref]
  5. Leroy EM, Epelboin A, Mondonge V, Pourrut X, Gonzalez JP, Muyembe-Tamfum JJ, Formenty P, , 2009. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis 9: 723728.[Crossref]
  6. Pigott DM, Golding N, Mylne A, Huang Z, Henry AJ, Weiss DJ, Brady OJ, Kraemer MU, Smith DL, Moyes CL, Bhatt S, Gething PW, Horby PW, Bogoch II, Brownstein JS, Mekaru SR, Tatem AJ, Khan K, Hay SI, , 2014. Mapping the zoonotic niche of Ebola virus disease in Africa. eLife 3: e04395.
  7. Marí Saéz A, Weiss S, Nowak K, Lapeyre V, Zimmermann F, Düx A, Kühl HS, Kaba M, Regnaut S, Merkel K, Sachse A, Thiesen U, Villányi L, Boesch C, Dabrowski PW, Radonić A, Nitsche A, Leendertz SA, Petterson S, Becker S, Krähling V, Couacy-Hymann E, Akoua-Koffi C, Weber N, Schaade L, Fahr J, Borchert M, Gogarten JF, Calvignac-Spencer S, Leendertz FH, , 2014. Investigating the zoonotic origin of the west African Ebola epidemic. EMBO Mol Med 7: 1723.[Crossref]
  8. Bausch DG, Schwarz L, , 2014. Outbreak of Ebola disease in Guinea: where ecology meets economy. PLoS Negl Trop Dis 8: e3056.[Crossref]
  9. Centers for Disease Control and Prevention, 2014. Cases of Ebola diagnosed in United States. Available at: http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/united-states-imported-case.html. Accessed January 23, 2015.
  10. Boguch II, Creatore MI, Cetron MS, Brownstein JS, Pesik N, Miniota J, Tam T, Hu W, Nicolucci A, Ahmed S, Yoon JW, Berry I, Hay SI, Anema A, Tatem AJ, MacFadden D, German M, Khan K, , 2015. Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak. Lancet 385: 2935.[Crossref]
  11. Chen T, Ka-Kit Leung R, Liu R, Chen F, Zhang X, Zhao J, Chen S, , 2014. Risk of imported Ebola virus disease in China. Travel Med Infect Dis 12: 650658.[Crossref]
  12. Rodríguez-Morales AJ, Henao DE, Franco TB, Mayta-Tristán P, Alfaro-Toloza P, Paniz-Mondolfi AE, , 2014. Ebola: a latent threat to Latin America. Are we ready? Travel Med Infect Dis 12: 688689.[Crossref]
  13. Rodríguez-Morales AJ, Marín-Rincón HA, Sepúlveda-Arias JC, Paniz-Mondolfi AE, , 2015. Assessing the potential migration of people from Ebola affected West African countries to Latin America. Travel Med Infect Dis 13: 264266.[Crossref]
  14. Kateh F, Nagbe T, Kieta A, Barskey A, Nasasira AN, Driscoll A, Tucker A, Christie A, Karmo B, Scott C, Bowah C, Barradas D, Blackley D, Dweh E, Warren F, Mahoney F, Kassay G, Calvert GM, Castro G, Logan G, Appiah G, Kirking H, Koon H, Papowitz H, Walke H, Cole IB, Montgomery J, Neatherlin J, Tappero JW, Hagan JE, Forrester J, Woodring J, Mott J, Attfield K, DeCock K, Lindblade KA, Powell K, Yeoman K, Adams L, Broyles LN, Slutsker L, Larway L, Belcher L, Cooper L, Santos M, Westercamp M, Weinberg MP, Massoudi M, Dea M, Patel M, Hennessey M, Fomba M, Lubogo M, Maxwell N, Moonan P, Arzoaquoi S, Gee S, Zayzay S, Pillai S, Williams S, Zarecki SM, Yett S, James S, Grube S, Gupta S, Nelson T, Malibiche T, Frank W, Smith W, Nyenswah T, , 2015. Rapid response to Ebola outbreaks in remote areas—Liberia, July–November 2014. MMWR 64: 188192.
  15. Allaranga M, Kone ML, Formenty P, Libama F, Boumandouki P, Woodfill CJ, Sow I, Duale S, Alemu W, Yada A, , 2010. Lessons learned during active epidemiological surveillance of Ebola and Marburg viral hemorrhagic fever epidemics in Africa. East Afr J Public Health 7: 3036.
  16. Mbonye AK, Wamala JF, Nanyunja M, Opio A, Makumbi I, Aceng JR, , 2014. Ebola viral hemorrhagic disease outbreak in west Africa—lessons from Uganda. Afr Health Sci 14: 495501.[Crossref]
  17. Tambo E, Ugwu EC, Ngogang JY, , 2014. Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries. Infect Dis Poverty 3: 29.[Crossref]
  18. Chunara R, Freifeld CC, Brownstein JS, , 2012. New technologies for reporting real-time emergent infections. Parasitology 139: 18431851.[Crossref]
  19. Boisen ML, Schieffelin JS, Goba A, Oottamasathien D, Jones AB, Shaffer JG, Hastie KM, Hartnett JN, Momoh M, Fullah M, Gabiki M, Safa S, Zandonatti M, Fusco M, Bornholdt Z, Abelson D, Gire SK, Andersen KG, Tariyal R, Stremlau M, Cross RW, Geisbert JB, Pitts KR, Geisbert TW, Kulakoski P, Wilson RB, Henderson L, Sabeti PC, Grant DS, Garry RF, Saphire EO, Branco LM, Khan SH, Viral Hemorrhagic Fever Consortium; , 2015. Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak. Viral Immunol 28: 1931.[Crossref]
  20. Schoepp RJ, Rossi CA, Khan SH, Goba A, Fair JN, , 2014. Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg Infect Dis 20: 11761182.[Crossref]
  21. World Health Organization, 2015. First Antigen Rapid Test for Ebola through Emergency Assessment and Eligible for Procurement. Available at: http://www.who.int/medicines/ebola-treatment/1st_antigen_RT_Ebola/en/. Accessed March 12, 2015.
  22. Corgenix Inc., 2015. Fact Sheet for Health Care Providers: Interpreting ReEBOV™ Antigen Rapid Test Results. February 24, 2015. Available at: http://www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM435524. Accessed March 19, 2015.
  23. Walker NF, Brown CS, Youkee D, Baker P, Williams N, Kalawa A, Russell K, Samba AF, Bentley N, Koroma F, King MB, Parker BE, Thompson M, Boyles T, Healey B, Kargbo B, Bash-Taqi D, Simpson AJ, Kamara A, Kamara TB, Lado M, Johnson O, Brooks T, , 2015. Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Lenone, January to February 2015. Euro Surveill 20: 21073.[Crossref]
  24. Yen CW, de Puig H, Tam JO, Gomez-Marquez J, Bosch I, Hamad-Schifferli K, Gehrke L, , 2015. Multicolored silver nanoparticles for multiplexed disease diagnostics: distinguishing dengue, yellow fever, and Ebola viruses. Lab Chip 15: 16381641.[Crossref]
  25. IntraHealth International, 2015. IntraHealth Receives Grand Challenge Award for Ebola Response. Available at: http://www.intrahealth.org/page/intrahealth-receives-grand-challenge-award-for-ebola-response. Accessed May 20, 2015.
  26. Wesolowski A, Buckee CO, Bengtsson L, Wetter E, Lu X, Tatem AJ, , 2014. Commentary: containing the Ebola outbreak—the potential and challenge of mobile network data. PLoS Curr 6: pii: ecurrents.outbreaks.0177e7fcf52217b8b634376e2f3efc5e.
  27. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keïta S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traoré A, Kolié M, Malano ER, Heleze E, Bocquin A, Mély S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, Günther S, , 2014. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 371: 14181425.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0229
Loading
  • Received : 23 Mar 2015
  • Accepted : 23 May 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error